Watchlist Price Alert

Spyre Therapeutics Inc. (SYRE)

NASDAQ: SYRE · Real-Time Price · USD

15.13

-2.05 (-11.93%)

At close: Jun 17, 2025, 3:41 PM

Spyre Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-208.02M	-338.79M	-83.81M	-65.8M	-80.89M	-78.25M	-44.35M	-27.24M	-21.7M
Depreciation & Amortization	n/a	744K	1.57M	1.58M	996K	901K	293K	249K	132K
Stock-Based Compensation	44.83M	25.68M	7.11M	8.04M	6.26M	n/a	n/a	n/a	n/a
Other Working Capital	-4.3M	-5.8M	-2.86M	768K	-2M	4.52M	3.88M	1.5M	976K
Other Non-Cash Items	10.31M	217.67M	823K	90K	619K	3.78M	1.93M	4.77M	1.07M
Deferred Income Tax	n/a	n/a	-327K	548K	-213K	n/a	n/a	n/a	n/a
Change in Working Capital	-4.53M	-5.21M	-5.5M	1.83M	-2.54M	7.1M	7.2M	-198K	1.45M
Operating Cash Flow	-157.41M	-99.91M	-80.14M	-53.72M	-75.78M	-65.69M	-32.19M	-24.61M	-18.84M
Capital Expenditures	n/a	n/a	-38K	-573K	-4.28M	-1.49M	-422K	-619K	-212K
Cash Acquisitions	n/a	3.04M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-599.25M	-166.8M	-39.5M	-133.08M	-129M	-91.93M	-62.18M	-64.11M	-20.39M
Sales Maturities Of Investments	245.97M	39.9M	96.55M	111.03M	125.68M	91.68M	47.37M	42.2M	8.45M
Other Investing Acitivies	n/a	15.47M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-353.29M	-108.39M	57.01M	-22.62M	-7.6M	-1.74M	-15.23M	-22.53M	-12.16M
Debt Repayment	n/a	-16K	-418K	-510K	-20K	-25K	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.43M	-5.38M	222K	1.9M	816K	1.45M	3.02M	833K	76K
Financial Cash Flow	410.91M	361.08M	42.68M	1.39M	154.51M	65.72M	57.07M	12.21M	49.37M
Net Cash Flow	-99.79M	152.8M	19.44M	-74.96M	71.18M	-3.21M	9.64M	-34.93M	18.37M
Free Cash Flow	-157.41M	-99.91M	-80.18M	-54.29M	-80.06M	-67.18M	-32.62M	-25.23M	-19.05M